MedTrace Logo

Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

NCT02378129 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-08-17

No results posted yet for this study

Summary

The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.

Conditions

  • Dentin Hypersensitivity

Interventions

DRUG

Resin-modified glass ionomer cement Clinpro XT

Clinpro XT (3M ESPE, Minnesota, USA)

DRUG

Glass Ionomer cement Vidrion R

Vidrion R (SS White, Gloucester, UK)

Sponsors & Collaborators

  • Federal University of Pelotas

    lead OTHER

Principal Investigators

  • Rafael G Lund, PhD · Federal University of Pelotas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
28 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-02
Primary Completion
2015-04-01
Completion
2015-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02378129 on ClinicalTrials.gov